Smallcap Pharma Stocks
as on 11 Nov 2026 at 3:58 PM2,034.60 | 0.15% | 4,36,260 | ₹ 33,061 | 81.50 | -95.96 | 2,422.30 | 1,086.70 | 1.91% | 0.67% | 52.10% | 748.63% | 371.51% | 6.40 | - | 3.77% | 6.45% | 13.12 | 2,032.77 | 1,725.74 | 56.83 | - | 79.73% | |
245.25 | -0.45% | 37,39,899 | ₹ 32,651 | -157.20 | -95.96 | 250.40 | 132.30 | 24.57% | 17.04% | 23.15% | 108.55% | 32.17% | 4.03 | 0.06% | -3.99% | 1.25% | -2.46 | 212.33 | 179.93 | 71.66 | - | 83.97% | |
3,916.90 | 0.88% | 5,17,440 | ₹ 32,068 | 72.40 | 18.95 | 4,045.30 | 1,570.00 | 23.93% | 18.77% | 121.92% | 608.56% | 648.10% | 17.09 | 0.06% | 20.83% | 27.72% | 43.51 | 3,380.81 | 2,905.65 | 64.56 | - | 80.56% | |
1,723.30 | -2.73% | 1,56,290 | ₹ 28,526 | 90.30 | 32.58 | 1,899.00 | 609.25 | 11.29% | 10.95% | 174.76% | 174.32% | 174.32% | 20.70 | 0.08% | 19.14% | 24.33% | 15.52 | 1,655.02 | 1,243.67 | 59.30 | - | 75.00% | |
20,204.00 | -0.58% | 78,744 | ₹ 25,922 | 57.60 | 18.95 | 24,225.00 | 11,500.00 | -3.28% | -11.60% | 13.27% | 284.06% | 1,120.42% | 12.85 | 0.17% | 19.42% | 23.11% | 283.71 | 21,192.20 | 17,616.57 | 50.91 | - | 75.00% | |
1,029.95 | 1.24% | 5,40,258 | ₹ 20,245 | 23.80 | -95.96 | 1,055.70 | 635.80 | 28.59% | 24.08% | 11.71% | 40.28% | 31.99% | 3.37 | 1.18% | 11.83% | 12.77% | 34.33 | 832.30 | 783.24 | 83.76 | - | 84.00% | |
799.25 | 0.01% | 46,36,738 | ₹ 19,805 | 30.50 | -95.96 | 923.65 | 529.85 | -1.96% | -8.54% | 44.10% | 115.96% | 149.30% | 3.31 | 0.22% | 11.70% | 15.98% | 24.47 | 836.22 | 747.14 | 42.34 | - | 84.00% | |
2,520.30 | 0.71% | 79,579 | ₹ 19,157 | 28.00 | 32.58 | 2,990.00 | 1,500.30 | 2.42% | -2.09% | 30.42% | 127.78% | 194.22% | 5.64 | 0.32% | 17.89% | 21.96% | 84.36 | 2,552.92 | 2,186.72 | 58.17 | - | 75.00% | |
934.15 | 0.03% | 6,63,053 | ₹ 18,270 | 55.00 | 32.58 | 1,095.00 | 259.50 | -8.57% | 22.95% | 153.47% | 422.89% | 218.63% | 6.63 | 0.06% | 9.39% | 12.39% | 12.44 | 964.08 | 608.80 | 48.96 | - | 75.00% | |
1,581.70 | -2.24% | 2,21,763 | ₹ 18,138 | -11,556.10 | -95.96 | 1,917.80 | 1,057.00 | 8.24% | 0.36% | -11.02% | -7.50% | -7.50% | 3.13 | - | -1.27% | 0.45% | -6.44 | 1,531.90 | 1,546.10 | 56.39 | - | 75.00% | |
1,454.90 | -1.32% | 9,26,050 | ₹ 17,862 | 27.10 | -95.96 | 1,574.00 | 819.00 | 9.70% | 9.41% | 59.00% | 130.79% | 128.36% | 5.00 | 0.34% | 16.94% | 21.78% | 45.99 | 1,382.72 | 1,147.45 | 55.78 | - | 84.00% | |
3,893.30 | -0.63% | 23,585 | ₹ 17,811 | 20.90 | -111.12 | 5,339.00 | 3,589.00 | 2.23% | -20.23% | -23.28% | 0.06% | -25.71% | 4.09 | 1.91% | 17.19% | 22.94% | 157.92 | 3,979.41 | 4,549.26 | 52.43 | - | 84.00% | |
464.10 | 4.61% | 14,49,930 | ₹ 17,756 | -2,955.70 | -95.96 | 715.00 | 266.70 | 5.24% | 4.12% | -34.41% | -16.62% | -8.15% | 4.34 | 1.35% | 3.72% | 4.81% | 4.69 | 451.65 | 409.61 | 54.95 | - | 75.00% | |
1,275.10 | 1.07% | 50,214 | ₹ 17,671 | 24.40 | 32.58 | 1,740.00 | 1,069.00 | 8.92% | -7.76% | -20.02% | 39.78% | 60.69% | 4.23 | 0.57% | 16.62% | 15.72% | 45.33 | 1,226.66 | 1,341.19 | 66.46 | - | 84.00% | |
6,507.00 | -0.12% | 11,968 | ₹ 16,268 | 91.60 | -111.12 | 9,469.50 | 5,640.00 | 11.48% | -20.56% | -28.32% | 32.46% | 114.83% | 18.52 | 0.55% | 21.49% | 25.48% | 75.01 | 6,380.16 | 7,845.46 | 61.33 | - | 75.00% | |
808.95 | 0.57% | 6,17,468 | ₹ 15,869 | 13.80 | -95.96 | 1,216.81 | 773.60 | 2.48% | -11.03% | 1.63% | 11.12% | -6.65% | 1.50 | 0.19% | 14.88% | 16.26% | 79.20 | 807.64 | 919.77 | 55.44 | - | 84.00% | |
987.50 | 2.23% | 1,03,221 | ₹ 15,729 | 43.80 | 18.95 | 1,162.00 | 786.05 | 5.97% | 5.95% | -12.39% | 145.74% | 59.58% | 2.17 | 0.52% | 5.60% | 6.36% | 25.15 | 973.11 | 941.91 | 60.44 | - | 84.00% | |
2,367.70 | -6.76% | 1,63,440 | ₹ 14,481 | 75.10 | -95.96 | 2,719.30 | 1,336.60 | 16.98% | 15.00% | 64.61% | 64.61% | 64.61% | 19.30 | 0.39% | 24.79% | 29.31% | 30.27 | 2,144.33 | 1,860.28 | 60.01 | - | 70.00% |
Total 18 records
*The scrips mentioned above are just for research purpose and not recommendations. Please do your own due diligence before investing.
Quick Links
FAQs on Small Cap Pharma Stocks
When selecting small cap pharma stocks, prioritize companies with a promising pipeline of drugs, positive cash flow, and manageable debt levels. Focus on those involved in high-growth therapeutic areas or with recent regulatory approvals. It's also essential to assess their market position and partnerships within the pharmaceutical industry.
